- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1043EUR$1,050USD£867GBP
€1490EUR$1,500USD£1,239GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1043EUR$1,050USD£867GBP
€1490EUR$1,500USD£1,239GBP
- Report
- January 2024
- 150 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- December 2023
- 109 Pages
Global
From €3974EUR$4,000USD£3,304GBP
- Report
- February 2024
- 73 Pages
Global
From €3500EUR$3,774USD£3,012GBP
- Report
- March 2024
- 143 Pages
Global
From €3576EUR$3,600USD£2,974GBP
- Report
- December 2023
- 221 Pages
Global
From €2781EUR$2,799USD£2,312GBP
- Report
- September 2024
- 112 Pages
Global
From €3974EUR$4,000USD£3,304GBP
- Report
- June 2024
Global
From €7451EUR$7,500USD£6,195GBP
- Report
- February 2024
- 226 Pages
Global
From €3974EUR$4,000USD£3,304GBP
- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- November 2024
- 50 Pages
Global
From €2633EUR$2,650USD£2,189GBP
- Report
- March 2024
- 95 Pages
Europe
From €1490EUR$1,500USD£1,239GBP
- Report
- March 2024
- 97 Pages
Asia Pacific
From €1490EUR$1,500USD£1,239GBP
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more